Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI)

NCT00251732 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Standard dose (once daily) PPI plus low-dose antidepressant
DRUG: Double dose PPI plus evening placebo
DRUG: Rabeprazole , placebo, placebo

Sponsor

University of Arizona

Collaborators

[object Object]
[object Object]